Epstein Secrets

s old when he attended ISIS military training. In March 2019, the DOJ said Emraan Ali and Jihad Ali surrendered to the Syrian Democratic Forces near Baghuz. The investigation and charges were announced by Assistant Attorney General for National Security John C. Demers, U.S. Attorney for the Southern Dis

g on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Lat

old when he attended ISIS military training. In March 2019, the DOJ said Emraan Ali and Jihad Ali surrendered to the Syrian Democratic Forces near Baghuz. The investigation and charges were announced by Assistant Attorney General for National Security John C. Demers, U.S. Attorney for the Southern Di

g on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Lat

s old when he attended ISIS military training. In March 2019, the DOJ said Emraan Ali and Jihad Ali surrendered to the Syrian Democratic Forces near Baghuz. The investigation and charges were announced by Assistant Attorney General for National Security John C. Demers, U.S. Attorney for the Southern Di

ring on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in La

s old when he attended ISIS military training. In March 2019, the DOJ said Emraan Ali and Jihad Ali surrendered to the Syrian Democratic Forces near Baghuz. The investigation and charges were announced by Assistant Attorney General for National Security John C. Demers, U.S. Attorney for the Southern Di

ng on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in La